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Introduction
Across the world, the prevalence of obesity has been growing in 
the public health area including children, adolescents and adults.1The 
population with obese or overweight would be about 33%.1 This trend 
also brings a variety of concerns due to high mortality and comorbidity 
in obese people and influence to medical and economic burden for 
each country. 2 As the prevalence of obesity and overweight becomes 
more, non-communicable diseases (NCDs) has been increasing 
more including diabetes mellitus, hypertension, dyslipidemia and 
arteriosclerotic diseases.3 They may bring several influences on 
medical, social and economic region.4 Diabetes mellitus cause chronic 
complications including macroangiopathy and microangiopathy. 
For the fundamental therapy for diabetes, nutritional treatment has 
been emphasized for long years by Calorie Restriction (CR), Low 
Carbohydrate Diet (LCD), and other types of regimen.5
Regarding nutritional treatment for obesity and diabetes, there has 
been a trend from CR to LCD. Lots of reports with comparison of 
these were found.6 Bernstein and Atkins had previously initiated LCD 
in the fields of medical and health area.7 After that, the predominance 
effect of LCD was observed in North American and European area.5,8 
On the other hand, authors et al. have started LCD at first in Japan in 
2000s.9 After that, we have continued clinical practice and reported 
a variety of research. They include glucose daily glucose profile, 
comparison of CR and LCD, ketone bodies (KB), meal tolerance 
test (MTT), continuous glucose monitoring (CGM), physiological 
role of KB in the axis of newborn, mother, placenta and fetus.10,11 
LCD seems to show stronger weight reducing effect for patients with 
obesity and diabetes in comparison with CR.12 There have been other 
treatments for reducing weight, which are surgery procedures. They 
include Endoscopic Sleeve Gastroplasty (ESG), Laparoscopic Sleeve 
Gastrectomy (LSG), Laparoscopic Band for Weight Loss, and so on.13 
LSG has been rather known for its simple and higher efficacy.14These 
operations have been increased worldwide, as patients with extreme 
obesity increase.
We have treated various patients with obesity so far. Among them, 
an obese female patient hoped to receive LSG, but could not have 
the operation because of severe diabetes. Then, we could successfully 
treat her with LCD. In this article, her general progress course and 
some discussion would be described. 
Case presentation
Present history: The case was 39-year old female patient with T2DM. 
She had unremarkable diseases until 24 years old. Her body weight 
was around 54kg until 28 years old. After marriage, her body weight 
had gradually increased up to 70kg. At 33 years old, she was pointed 
out to have T2DM, and started to receive oral hyperglycemic agents 
(OHA). However, her glucose variability had not improved, then she 
had been on several medicine for diabetes from 36 years old.As her 
body weight had been increased further, she became to hope reducing 
the weight by the surgery procedure. The patient had a strong hope 
to receive Laparoscopic sleeve gastrectomy (LSG). She often visited 
the surgery clinic in Tokyo, but she could not take the operation of 
LSG. Some reasons included i) her BMI was 33.3, which was lower 
than 35.0, ii) diabetic condition was too bad to be tolerated for the 
operation. Consequently, she was introduced to our diabetes clinic for 
further evaluation and treatment.
Physicals: Her physicals were evaluated in detail. She had normal 
consciousness and vitals including pulse, blood pressure, respiration, 
body temperature. There were no remarkable changes in the lung, 
heart and abdomen. She showed slight peripheral neuropathy in the 
hands and feet, no apparent retinopathy or nephropathy. Furthermore, 
there were no signs or symptoms related to hyper- or hypoglycemia. 
She has moderate obesity, with the body mass index (BMI) of 33.3 
kg/m2.
Laboratory exam: The data of the laboratory tests in complete blood 
count (CBC) and biochemical data were revealed as follows: WBC 
6200/μL, RBC 4.16 x 106/μL, Hb 13.3 g/dL, Plt 19.4 x 104/μL, AST 
25 IU/mL, ALT 35 IU/mL, ALP 202 IU/mL (100-340), LD 164 IU/
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Abstract
The case was 39-year old female patient with T2DM (BMI 33.3). She had a strong hope 
to receive Laparoscopic sleeve gastrectomy (LSG), but she could not take the operation of 
LSG because of severe diabetic control (HbA1c 11.4%). She was treated with 5 kinds of 
diabetic medicine such as, Exenatide, Alogliptin, Metformin, Mitiglinide and Miglitol. She 
continued LCD successfully, with the improvement of HbA1c 10.8 % to 6.3% and weight 
reduction 83.2 kg to 66.6 kg. At 7 months, medicine was only Metformin. In our activity 
of Japan LCD Promotion Association (JLCDPA), super-LCD has been effective with 12% 
of carbohydrate.
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mL (100-210), T-Bil 0.6 mg/dL, BUN 15 mg/dL, Cre 0.7 mg/dL, Uric 
Acid 5.2mg/dL, Na 142mmol/L, K 4.1 mmol/L, Cl 102 mmol/L, HDL 
64mg/dL, LDL 151mg/dL, TG 207mg/dL. Data related diabetes were 
HbA1c 11.8% and post-prandial blood glucose 356mg/dL.
Clinical progress
Before our visit, the patient showed high HbA1c value as 11-12% 
for months. At that time, she was treated with 5 kinds of medicine 
for diabetes. They included GLP-1 receptor agonist (Exenatide, 2mg/
week, D04121), DPP4-inhibitor (Alogliptin 25mg /day, D06553), 
Metformin 1000mg/day, Mitiglinide calcium hydrate 30mg/day and 
Miglitol 150mg/day. After our visit, we have explained the patient 
the significance and method of super-LCD (12% of carbohydrate). 
She understood well and started and continued super-LCD for long 
months. Consequently, her HbA1c decreased from 10.8 % to 6.3%, 
and body weight also decreased from 83.2 kg to 66.6 kg for 7 months 
(Figure 1). This clinical course was satisfactory in the light of diabetes 
and obesity. She did not have to consider the operation of LSG. At 7 
months, she had on only Metformin 500mg/day as the prescription. 
Figure 1 Clinical course of the case with HbA1c, blood glucose and body weight. 
Discussion
Authors and colleagues have begun LCD in Japan and developed 
LCD in medical and social area. We established Japan LCD Promotion 
Association (JLCDPA), and continued various activities. They include 
English papers, books about how to continue LCD, lectures for LCD, 
cooking workshops for LCD, and so on.15 There are many divisions 
of JLCDPA in Japan so far, and we developed anti-aging movement 
with LCD, adequate exercise and ordinary life style habit.16 In order 
to propose a simple and easy to understand protocol of LCD, we have 
proposed three types of LCDs. They are petite-LCD, standard-LCD 
and super-LCD. Those LCDs have the ratio of carbohydrate by calorie 
measurement a day as 40%, 26% and 12%.17 In the case of super-
LCD with 1400 kcal/day, the carbohydrate is 168 kcal/day, because 
including 12% of carbohydrate. The calorie 168kcal of carbohydrate 
(4 kcal/g) means taking 42g of carbohydrate a day. Consequently, 
super-LCD generally means the limited intake of carbohydrate about 
42g a day. When super-LCD is provided to diabetic patient with 
remarkable high glucose profile, glucose variability will be drastically 
improved within 2 days.17
LSG has been well-known restrictive bariatric surgical procedure 
for the surgery of the obesity. The reason would be from rather 
simple technique, satisfactory effect for weight loss and reduced 
morbidities.14 There was a comparison study of surgical interventions 
between LSG and Endoscopic Sleeve Gastroplasty (ESG) by cohort 
study.13 As a result, LSG showed greater reduction of BMI and percent 
total body weight loss (%TBWL) than those of ESG at 12 months 
(29.3% vs 17.6%, significant difference).18
For LSG, systematic review of 27 relevant articles with 5218 cases 
were studied.19 It showed as follows: mean age was 41.1 years old, 
BMI decreased from 43.8±8.0 to 30.7±3.9 (1 year), remission rate 
of diabetes, hypertension and dyslipidemia was 81.9%, 66.5% and 
64.1%, respectively.19 These results show the efficacy of LSG. Quality 
of Life (QOL) after the operation of LSG were investigated.20From 
702 reports, 13 articles with 1630 cases in total were analyzed. Six 
kinds of QoL assessment tools were used. As a result, SF-36 revealed 
significant improvement between pre- and post-operative assessment. 
From BAROS score, 77-96% of cases evaluated achieving “good” to 
“excellent” outcomes.20
Historically speaking, there were different dietary approaches for 
diabetes and obesity. They include CR, Mediterranean, vegetarian, 
moderate carbohydrate, LCD, high-protein, low glycemic index/ 
glycemic load (GI/GL) and others.21 According to the comment of on 
American Diabetes Association (ADA) and European Association for 
the Study of Diabetes (EASD), LCDs have been recommended for 
the treatment of diabetic patients.22 LCD has been defined as the meal 
with carbohydrate less than 26% of total daily energy intake. LCD has 
been known to have beneficial effect for improving glucose variability 
in diabetic patients. In contrast, there was no additional effect in the 
case of moderate restriction (26-45%) of carbohydrate.22,23
 In our previous report, we investigated 2699 cases of obesity 
with the treatment of LCD.24 As a result, the patient ratio of weight 
reduction more than 10% was 25.6%, and those more than 5% was 
57.6%. This clinical achievement would be satisfactory by LCD.24 
The energy proportion of carbohydrate intake in a day would be 
furthermore studied including several factors such as longer term, 
countries and nutritional recommendations.25 In summary, a female 
patient withT2DM case was described. Her characteristic points 
include trying to receive LSG, successful LCD continuation and 
remarkable effects for HbA1c and weight reduction. Hopefully this 
information will be reference data for future clinical diabetic research.
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